We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Gains But Lags Market: What You Should Know
Read MoreHide Full Article
Intuitive Surgical, Inc. (ISRG - Free Report) closed the most recent trading day at $293.51, moving +1.78% from the previous trading session. The stock lagged the S&P 500's daily gain of 2.24%. Meanwhile, the Dow gained 2.51%, and the Nasdaq, a tech-heavy index, lost 0.2%.
Heading into today, shares of the company had gained 9.75% over the past month, outpacing the Medical sector's loss of 1% and the S&P 500's loss of 2.58% in that time.
Intuitive Surgical, Inc. will be looking to display strength as it nears its next earnings release. On that day, Intuitive Surgical, Inc. is projected to report earnings of $1.07 per share, which would represent a year-over-year decline of 8.55%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.44 billion, up 11.79% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $4.87 per share and revenue of $6.34 billion. These totals would mark changes of -1.81% and +11.11%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for Intuitive Surgical, Inc.These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Intuitive Surgical, Inc. currently has a Zacks Rank of #4 (Sell).
Looking at its valuation, Intuitive Surgical, Inc. is holding a Forward P/E ratio of 59.26. This valuation marks a premium compared to its industry's average Forward P/E of 35.51.
Meanwhile, ISRG's PEG ratio is currently 5.93. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Medical - Instruments stocks are, on average, holding a PEG ratio of 3.02 based on yesterday's closing prices.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 176, which puts it in the bottom 31% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Gains But Lags Market: What You Should Know
Intuitive Surgical, Inc. (ISRG - Free Report) closed the most recent trading day at $293.51, moving +1.78% from the previous trading session. The stock lagged the S&P 500's daily gain of 2.24%. Meanwhile, the Dow gained 2.51%, and the Nasdaq, a tech-heavy index, lost 0.2%.
Heading into today, shares of the company had gained 9.75% over the past month, outpacing the Medical sector's loss of 1% and the S&P 500's loss of 2.58% in that time.
Intuitive Surgical, Inc. will be looking to display strength as it nears its next earnings release. On that day, Intuitive Surgical, Inc. is projected to report earnings of $1.07 per share, which would represent a year-over-year decline of 8.55%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.44 billion, up 11.79% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $4.87 per share and revenue of $6.34 billion. These totals would mark changes of -1.81% and +11.11%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for Intuitive Surgical, Inc.These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Intuitive Surgical, Inc. currently has a Zacks Rank of #4 (Sell).
Looking at its valuation, Intuitive Surgical, Inc. is holding a Forward P/E ratio of 59.26. This valuation marks a premium compared to its industry's average Forward P/E of 35.51.
Meanwhile, ISRG's PEG ratio is currently 5.93. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Medical - Instruments stocks are, on average, holding a PEG ratio of 3.02 based on yesterday's closing prices.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 176, which puts it in the bottom 31% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.